Clinical Trial Update: Food Effects on the Relative Bioavailability of Different Dosages of Risedronate [Phase 1]

View source ↗

Summary

Phase 1 study assessing how meals affect the relative bioavailability of various doses of risedronate in postmenopausal women. The trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postmenopausal Osteoporosis

Drugs mentioned

• risedronate (risedronate)

Snippet

Sponsor: Warner Chilcott | Conditions: Postmenopausal, Non-lactating | Phase 1 | Status: COMPLETED